Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anika Therapeutics (ANIK) Inventory Average (2016 - 2026)

Anika Therapeutics has reported Inventory Average over the past 16 years, most recently at $20.8 million for Q1 2026.

  • Quarterly Inventory Average fell 7.8% to $20.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $20.8 million through Mar 2026, down 7.8% year-over-year, with the annual reading at $21.3 million for FY2025, 11.69% down from the prior year.
  • Inventory Average was $20.8 million for Q1 2026 at Anika Therapeutics, up from $17.5 million in the prior quarter.
  • Over five years, Inventory Average peaked at $50.4 million in Q2 2024 and troughed at $16.6 million in Q3 2025.
  • The 5-year median for Inventory Average is $35.6 million (2022), against an average of $33.3 million.
  • Year-over-year, Inventory Average grew 20.2% in 2024 and then tumbled 63.55% in 2025.
  • A 5-year view of Inventory Average shows it stood at $38.5 million in 2022, then fell by 11.49% to $34.1 million in 2023, then decreased by 6.92% to $31.7 million in 2024, then tumbled by 44.72% to $17.5 million in 2025, then rose by 18.69% to $20.8 million in 2026.
  • Per Business Quant, the three most recent readings for ANIK's Inventory Average are $20.8 million (Q1 2026), $17.5 million (Q4 2025), and $16.6 million (Q3 2025).